Atlas Trials

Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants

Clinical trial NCT01749137 · COMPLETED

Trial details

NCT number
NCT01749137
Sponsor
Rhythm Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Overweight
Start date
2013-01-14
Primary completion
2013-09-28
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.